Feedback / Questions
glycopyrrolate/indacaterol (AERO-007) - AeroRx Therapeutics
https://www.businesswire.com/news/home/20250730117975/en/AeroRx-Therapeutics-Announces-Topline-Positive-Phase-2a-Data-for-Inhaled-AERO-007-the-First-Nebulized-LABALAMA-Combination-in-Development-for-COPD
Jul 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next